RARA CRAFT DATABASE for FDA Medical Devices
510(k)K202019

FDA DEVICE FACTS

Maven Patient-Specific Instrumentation

Paragon 28, Inc.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEJanuary 14, 2021PRODUCT CODEHSN

Indications for use

Complete subject indications for use

The Paragon 28 MAVEN™ Patient-Specific Instrument ation is intended to be used as patient specific surgical instrumentation to assist in the positioning of total ankle replacement components intraoperatively and in guiding the marking of bone before cu tting. The Paragon 28 MAVEN™ Patient-Specific Instrumentation is intended for use with the Pa ragon 28 APEX 3D Total Ankle Replacement System and its cleared indications for use, provided that anatomic landmarks necessary for alignment and posi tioning of the implant are iden tifiable on patient imaging CT scans. The Paragon 28 MAVEN™ Patient-Specific Instrumentation is intended for single use only. The Paragon 28 TAR Patient-Specific Case Reports are intended for use with the Paragon 28 APEX 3D Total Ankle Replacement System and its cleared indications for use, provided that

Paragon 28 MAVEN™ Patient-Specific Instrumentation – Traditional 510(k) 2 anatomic landmarks necessary for alignment a nd positioning of the implant are identifiable on patient imaging CT scans.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 24, 2026